By Omar Ford
Medical Device Daily

August 19, 2011, Medical Device Daily -- After a few minor hurdles, Cambridge Heart (Tewksbury, Massachusetts) is putting itself in a position to gain greater adoption for its lead product, the Microvolt T-Wave Alternans (MTWA) test, as well as gain a new indication for the application.

Cambridge Heart CEO Ali Haghighi-Mood spoke with Medical Device Daily yesterday about the firm's MTWA test and an upcoming pilot trial that could secure some additional regulatory approvals for the product.

Read the complete interview.